Paradigm Biocapital Advisors as of March 31, 2022
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 25 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 10.0 | $38M | 322k | 117.36 | |
| Global Blood Therapeutics In | 8.9 | $34M | 967k | 34.64 | |
| Arvinas Ord (ARVN) | 8.7 | $33M | 491k | 67.30 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 8.0 | $30M | 832k | 36.34 | |
| Sierra Oncology Com New | 6.5 | $25M | 771k | 32.05 | |
| Miragen Therapeutics (VRDN) | 6.1 | $23M | 1.3M | 18.49 | |
| Incyte Corporation (INCY) | 4.9 | $19M | 234k | 79.42 | |
| Iveric Bio | 4.1 | $15M | 910k | 16.83 | |
| Iovance Biotherapeutics (IOVA) | 4.0 | $15M | 907k | 16.65 | |
| Immunocore Hldgs Ads (IMCR) | 3.9 | $15M | 499k | 29.90 | |
| Horizon Therapeutics Pub L SHS | 3.8 | $14M | 136k | 105.21 | |
| United Therapeutics Corporation (UTHR) | 3.6 | $14M | 76k | 179.41 | |
| Zentalis Pharmaceuticals (ZNTL) | 3.5 | $13M | 288k | 46.14 | |
| Syndax Pharmaceuticals (SNDX) | 3.2 | $12M | 701k | 17.38 | |
| C4 Therapeutics Com Stk (CCCC) | 3.2 | $12M | 500k | 24.26 | |
| Oyster Point Pharma | 3.0 | $12M | 988k | 11.64 | |
| Prothena Corp SHS (PRTA) | 2.6 | $9.8M | 268k | 36.57 | |
| Kymera Therapeutics (KYMR) | 2.5 | $9.6M | 227k | 42.32 | |
| Mirati Therapeutics | 2.1 | $8.1M | 98k | 82.22 | |
| Merus N V (MRUS) | 1.7 | $6.6M | 250k | 26.44 | |
| Vor Biopharma (VOR) | 1.4 | $5.4M | 894k | 6.04 | |
| Esperion Therapeutics (ESPR) | 1.4 | $5.4M | 1.2M | 4.64 | |
| Fulcrum Therapeutics (FULC) | 1.3 | $5.0M | 213k | 23.65 | |
| Alpine Immune Sciences (ALPN) | 0.8 | $3.0M | 336k | 8.97 | |
| Gracell Biotechnologies Sponsored Ads | 0.5 | $1.8M | 783k | 2.33 |
